导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -1.86% | 2915/4773 |
| 近一周 | -2.44% | 3882/5465 |
| 近一月 | -5.87% | 3925/5421 |
| 近一季 | -6.29% | 2356/5231 |
| 近半年 | -2.64% | 2221/4920 |
| 近一年 | -1.54% | 2974/4394 |
| 近两年 | 36.05% | 2073/2954 |
| 近三年 | 18.54% | 1545/2253 |
| 成立以来 | 36.14% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.02% 3001/4961 |
11.57% 2318/5312 |
- - |
- - |
| 2025 | 13.07% 2663/4813 |
-0.10% 2060/3635 |
0.04% 2772/4076 |
15.33% 2815/4524 |
-1.91% 3034/4813 |
| 2024 | 16.20% 835/3463 |
3.94% 495/2808 |
-2.30% 1171/3014 |
18.99% 902/3129 |
-3.83% 2393/3463 |
| 2023 | -8.38% 1008/2656 |
4.92% 857/2280 |
-3.05% 736/2385 |
-2.42% 674/2515 |
-7.70% 2192/2655 |
| 2022 | -18.17% 673/2207 |
-11.45% 514/1919 |
5.56% 875/2016 |
-14.89% 1167/2113 |
2.85% 817/2208 |
| 2021 | 2.08% 638/1822 |
0.36% 299/1255 |
4.95% 836/1330 |
-4.85% 742/1466 |
1.85% 778/1822 |
| 2020 | - - |
- - |
8.80% 811/1067 |
15.18% 232/1164 |
16.88% 145/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4546 | 31.90% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.3128 | 30.52% |
| 中欧中证港股通创新药指数发起A | 1.6103 | 30.52% |
| 嘉实中证港股通创新药指数发起式C | 0.8566 | 30.50% |
| 中欧中证港股通创新药指数发起C | 1.4583 | 30.44% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8927 | 30.26% |
| 景顺长城中证港股通创新药ETF联接C | 1.4696 | 29.97% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8736 | 29.94% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8719 | 29.88% |
| 博时可持续发展100ETF VS. 长安沪深300非周期A(740101) |